Dopaminergic agonist therapy is a commonly used treatment, but its important to consider the potential down-regulation of dopamine receptors rather than up-regulation of D2 receptors
[DOI] [PubMed] [Google Scholar] 23.Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al
They evaluated the cost of each intervention, including cost of complications, and assessed how much cost was incurred to achieve each quality adjusted life year (QALY) over a 5-year time horizon (with 3% discounting)
Dose increases are supposed to follow the slow titration schedule for a reason
Naley rwnie unika zamraania roztworu , poniewa niskie temperatury mog uszkodzi struktur peptydu
[PMC free article] [PubMed] [Google Scholar] 19.Antonicelli F, Parmentier M, Drost EM, Hirani N, Rahman I, Donaldson K, et al